Published in J Virol on August 01, 1979
Identification of regulatory sequences in the prelude sequences of an H2A histone gene by the study of specific deletion mutants in vivo. Proc Natl Acad Sci U S A (1980) 16.88
Analysis of an activatable promoter: sequences in the simian virus 40 late promoter required for T-antigen-mediated trans activation. Mol Cell Biol (1985) 2.55
Sequences at the capped 5'-ends of polyoma virus late region mRNAs: an example of extreme terminal heterogeneity. Nucleic Acids Res (1981) 2.32
Characterization of the 5'-terminal cap structures of early simian virus 40 mRNA. J Virol (1980) 1.95
Unspliced functional late 19S mRNAs containing intervening sequences are produced by a late leader mutant of simian virus 40. Proc Natl Acad Sci U S A (1981) 1.71
Initiation of transcription by RNA polymerase II in permeable, SV40-infected or noninfected, CVI cells; evidence for multiple promoters of SV40 late transcription. Nucleic Acids Res (1981) 1.71
Simian virus 40 agnoprotein facilitates normal nuclear location of the major capsid polypeptide and cell-to-cell spread of virus. J Virol (1986) 1.67
Localization of three major cappe 5' ends of polyoma virus late mRNA's within a single tetranucleotide sequence in the viral genome. J Virol (1980) 1.66
Characterization of the major altered leader sequence of late mRNA induced by SV40 deletion mutant d1-1811. Nucleic Acids Res (1979) 1.52
Mutants deleted in the agnogene of simian virus 40 define a new complementation group. J Virol (1983) 1.48
Altered utilization of splice sites and 5' termini in late RNAs produced by leader region mutants of simian virus 40. J Virol (1982) 1.40
Sequences locating the 5' ends of the major simian virus 40 late mRNA forms. J Virol (1983) 1.31
Subcellular localization of the simian virus 40 agnoprotein. J Virol (1983) 1.29
Simian virus 40 late promoter region able to initiate simian virus 40 early gene transcription in the absence of the simian virus 40 origin sequence. J Virol (1984) 1.29
Specific in vitro initiation of transcription of simian virus 40 early and late genes occurs at the various cap nucleotides including cytidine. Proc Natl Acad Sci U S A (1981) 1.28
Simian virus 40 early mRNA's in lytically infected and transformed cells contain six 5'-terminal caps. J Virol (1981) 1.25
Sequences involved in determining the locations of the 5' ends of the late RNAs of simian virus 40. J Virol (1985) 1.24
Construction and characterization of CV-1P cell lines which constitutively express the simian virus 40 agnoprotein: alteration of plaquing phenotype of viral agnogene mutants. J Virol (1986) 1.20
Simian virus 40 agnoprotein facilitates perinuclear-nuclear localization of VP1, the major capsid protein. J Virol (1986) 1.18
Missense mutations in the VP1 gene of simian virus 40 that compensate for defects caused by deletions in the viral agnogene. J Virol (1987) 1.02
Characterization of the simian virus 40 late promoter: relative importance of sequences within the 72-base-pair repeats differs before and after viral DNA replication. J Virol (1987) 1.01
Simian virus 40 mutants carrying extensive deletions in the 72-base-pair repeat region. J Virol (1983) 1.01
Human Cu/Zn superoxide dismutase gene: molecular characterization of its two mRNA species. Nucleic Acids Res (1984) 1.00
Role of the agnoprotein in regulation of simian virus 40 replication and maturation pathways. J Virol (1987) 0.90
Effects of the adenovirus 2 late promoter on simian virus 40 transcription and replication. J Virol (1986) 0.89
Contribution of different GC-motifs to the control of simian virus 40 late promoter activity. Nucleic Acids Res (1987) 0.86
Spontaneous deletion mutants resulting from a frameshift insertion in the simian virus 40 agnogene. J Virol (1986) 0.83
Transcription pattern of in vivo-labeled late simian virus 40 RNA: evidence that 16S and 19S mRNA's are derived from distinct precursor RNA populations. J Virol (1980) 0.80
Expression of the late gene of simian virus 40 under the control of the simian virus 40 early-region promoter in monkey and mouse cells. J Virol (1986) 0.77
Sequences of ribosome binding sites from the large size class of reovirus mRNA. J Virol (1982) 0.77
The growth of simian virus 40 (SV40) host range/adenovirus helper function mutants in an African green monkey cell line that constitutively expresses the SV40 agnoprotein. J Virol (1990) 0.76
A new method for sequencing DNA. Proc Natl Acad Sci U S A (1977) 250.51
FURTHER STUDIES ON THE ALKYLATION OF NUCLEIC ACIDS AND THEIR CONSTITUENT NUCLEOTIDES. Biochem J (1963) 25.31
How do eucaryotic ribosomes select initiation regions in messenger RNA? Cell (1978) 12.04
Nucleic acid hybridization using DNA covalently coupled to cellulose. Cell (1975) 11.26
Construction and analysis of viable deletion mutants of simian virus 40. J Virol (1976) 9.11
Heterogeneity and 5'-terminal structures of the late RNAs of simian virus 40. J Mol Biol (1978) 7.64
Mapping the spliced and unspliced late lytic SV40 RNAs. Cell (1978) 4.25
Viable deletion mutants of simian virus 40: selective isolation by means of a restriction endonuclease from Hemophilus parainfluenzae. Proc Natl Acad Sci U S A (1974) 3.71
The 5'-terminal leader sequence of late 16 S mRNA from cells infected with simian virus 40. J Biol Chem (1978) 3.60
Micro thin-layer techniques for rapid sequence analysis of 32P-labeled RNA: double digestion and pancreatic ribonuclease analyses. Anal Biochem (1977) 3.18
Rapid sequence determination of late simian virus 40 16S mRNA leader by using inhibitors of reverse transcriptase. Proc Natl Acad Sci U S A (1979) 3.16
Comparison of the nucleotide sequence of the messenger RNA for the major structural protein of SV40 with the DNA sequence encoding the amino acids of the protein. Nucleic Acids Res (1977) 3.00
Methylated simian virus 40-specific RNA from nuclei and cytoplasm of infected BSC-1 cells. Proc Natl Acad Sci U S A (1975) 2.81
RNAs of simian virus 40 in productively infected monkey cells: kinetics of formation and decay in enucleate cells. Proc Natl Acad Sci U S A (1975) 2.77
Mutational alterations within the simian virus 40 leader segment generate altered 16S and 19S mRNA's. J Virol (1979) 2.61
Gaps and duplicated sequences in the leaders of SV40 16S RNA. Nucleic Acids Res (1978) 2.60
Mechanism of formation of reovirus mRNA 5'-terminal blocked and methylated sequence, m7GpppGmpC. J Biol Chem (1976) 2.60
Simian virus 40 transcription in productively infected and transformed cells. J Virol (1974) 2.30
Multiple 5' terminal cap structures in late polyoma virus RNA. Cell (1979) 2.21
A micromethod for base analysis of 32P-labeled oligoribonulcleotides. Anal Biochem (1977) 2.21
Post-transcriptional and translational controls of gene expression in eukaryotes. Annu Rev Biochem (1978) 2.06
Transcription of simian virus 40. V. Regulattion of simian virus 40 gene expression. J Virol (1975) 1.90
Localization of the 5' terminus of late SV40 mRNA. Nucleic Acids Res (1978) 1.80
5'-Terminal capping of RNA by guanylyltransferase from HeLa cell nuclei. Proc Natl Acad Sci U S A (1977) 1.77
"Pretranscriptional capping" in the biosynthesis of cytoplasmic polyhedrosis virus mRNA. Proc Natl Acad Sci U S A (1978) 1.67
Influence of 5'-terminal cap structure on the initiation of translation of vaccinia virus mRNA. J Biol Chem (1978) 1.62
Evidence for 'splicing' of SV40 16S mRNA. Nature (1978) 1.56
Synthesis methylation, and capping of nuclear RNA by a subcellular system. Biochemistry (1976) 1.46
Characterization of the 5'-terminal capped structures of late simian virus 40-specific mRNA. J Virol (1978) 1.36
Functions of the 5,-terminal m7G cap in eukaryotic mRNA. FEBS Lett (1978) 1.30
Capping structures of simian virus 40 19S and 16S mRNAs. Nucleic Acids Res (1977) 1.29
Spatial configuration of mRNA 5'-terminus. Nature (1977) 1.15
Selective degradation of newly synthesized nonmessenger simian virus 40 transcripts. J Virol (1978) 1.03
Different cap 1 : cap 2 ratios in rabbit alpha and beta globin mRNA. Nature (1978) 0.97
Methylated nucleosides in globin mRNA from mouse nucleated erythroid cells. J Biol Chem (1977) 0.83
Complete nucleotide sequence of SV40 DNA. Nature (1978) 24.07
Complete structure of the hemagglutinin gene from the human influenza A/Victoria/3/75 (H3N2) strain as determined from cloned DNA. Cell (1980) 14.28
Preferential codon usage in prokaryotic genes: the optimal codon-anticodon interaction energy and the selective codon usage in efficiently expressed genes. Gene (1982) 11.99
Plasmid vectors for high-efficiency expression controlled by the PL promoter of coliphage lambda. Gene (1981) 9.44
Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell (1991) 8.75
Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol (1986) 8.22
Studies on in vitro transformation by DNA and DNA fragments of human adenoviruses and simian virus 40. Cold Spring Harb Symp Quant Biol (1975) 7.76
Preparative two-dimensional polyacrylamide gel electrophoresis of 32 P-labeled RNA. Anal Biochem (1972) 7.53
Complete nucleotide sequence of bacteriophage MS2 RNA: primary and secondary structure of the replicase gene. Nature (1976) 6.36
Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science (2000) 6.19
Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci U S A (1986) 5.83
Cleavage map of the simian-virus-40 genome by the restriction endonuclease III of Haemopholus aegyptius. Eur J Biochem (1976) 5.31
Antigenic drift between the haemagglutinin of the Hong Kong influenza strains A/Aichi/2/68 and A/Victoria/3/75. Nature (1980) 5.25
Nucleotide sequence of the gene coding for the bacteriophage MS2 coat protein. Nature (1972) 5.05
Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro. Proc Natl Acad Sci U S A (1986) 5.03
Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon. J Exp Med (1983) 4.92
Improved plasmid vectors with a thermoinducible expression and temperature-regulated runaway replication. Gene (1983) 4.87
A universal influenza A vaccine based on the extracellular domain of the M2 protein. Nat Med (1999) 4.82
Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. Proc Natl Acad Sci U S A (1984) 4.43
Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med (1993) 4.30
Nucleotide sequence of the Hind-C fragment of simian virus 40 DNA. Comparison of the 5'-untranslated region of wild-type virus and of some deletion Mutants. Eur J Biochem (1979) 4.24
Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon. Nature (1983) 4.16
Isolation and structure of a human fibroblast interferon gene. Nature (1980) 4.16
Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J Exp Med (1998) 4.08
Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J Biol Chem (1992) 3.76
Two tumour necrosis factor receptors: structure and function. Trends Cell Biol (1995) 3.67
Evidence for tumour necrosis factor/cachectin production in cancer. Lancet (1987) 3.66
Structural analysis of the sequence coding for an inducible 26-kDa protein in human fibroblasts. Eur J Biochem (1986) 3.63
Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature (1995) 3.59
Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. J Biol Chem (1999) 3.57
The GAG precursor of simian immunodeficiency virus assembles into virus-like particles. EMBO J (1989) 3.50
Molecular cloning of human interleukin 2 cDNA and its expression in E. coli. Nucleic Acids Res (1983) 3.44
The 3' untranslated region of the human interferon-beta mRNA has an inhibitory effect on translation. Proc Natl Acad Sci U S A (1987) 3.37
Secondary structure of mRNA and efficiency of translation initiation. Gene (1980) 3.18
Micro thin-layer techniques for rapid sequence analysis of 32P-labeled RNA: double digestion and pancreatic ribonuclease analyses. Anal Biochem (1977) 3.18
Simple, efficient in vitro synthesis of capped RNA useful for direct expression of cloned eukaryotic genes. Nucleic Acids Res (1982) 3.12
Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species. J Immunol (1987) 3.06
Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J (1993) 2.98
p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor. J Biol Chem (1998) 2.97
Recombinant tumor necrosis factor and immune interferon act singly and in combination to reorganize human vascular endothelial cell monolayers. Am J Pathol (1986) 2.95
Lysis gene expression of RNA phage MS2 depends on a frameshift during translation of the overlapping coat protein gene. Nature (1982) 2.77
Studies on the bacteriophage MS2. The untranslated 5'-terminal nucleotide sequence preceding the first cistron. Eur J Biochem (1971) 2.76
Analysis of 32P-labeled bacteriophage MS2 RNA by a mini-fingerprinting procedure. Anal Biochem (1976) 2.67
Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. Proc Natl Acad Sci U S A (1995) 2.67
The p38/RK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO J (1996) 2.64
A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific alpha chain and a beta chain shared with the receptor for GM-CSF. Cell (1991) 2.49
Genes for the tumor necrosis factors alpha and beta are linked to the human major histocompatibility complex. Proc Natl Acad Sci U S A (1986) 2.42
Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated 'acute phase response' in the brain? Immunol Today (1991) 2.41
Recombinant interleukin-2 directly augments the cytotoxicity of human monocytes. Nature (1987) 2.31
B cell growth modulating and differentiating activity of recombinant human 26-kd protein (BSF-2, HuIFN-beta 2, HPGF). EMBO J (1987) 2.30
Cloned human interferon-gamma, but not interferon-beta or -alpha, induces expression of HLA-DR determinants by fetal monocytes and myeloid leukemic cell lines. J Immunol (1984) 2.26
Nucleotide sequence deletions within the coding region for small-t antigen of simian virus 40. J Virol (1979) 2.23
A micromethod for base analysis of 32P-labeled oligoribonulcleotides. Anal Biochem (1977) 2.21
Evidence for the direct involvement of DNA replication origin in synthesis of late SV40 RNA. Nature (1982) 2.20
Binding of human tumor necrosis factor to high affinity receptors on HeLa and lymphoblastoid cells sensitive to growth inhibition. J Biol Chem (1985) 2.18
The nuclear factor-kappaB engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter. J Biol Chem (1999) 2.15
Bacteriophage Ms2 RNA: nucleotide sequence of the end of the a protein gene and the intercistronic region. Nat New Biol (1973) 2.15
Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. J Exp Med (1998) 2.11
The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors. Proc Natl Acad Sci U S A (1987) 2.10
Expression and characterization of the product of a human immune interferon cDNA gene in Chinese hamster ovary cells. Proc Natl Acad Sci U S A (1983) 2.09
A-protein gene of bacteriophage MS2. Nature (1975) 2.08
Molecular cloning of human immune interferon cDNA and its expression in eukaryotic cells. Nucleic Acids Res (1982) 2.01
Induction of the synthesis of tumor necrosis factor receptors by interferon-gamma. J Immunol (1986) 2.00
Complete DNA sequence of yeast chromosome II. EMBO J (1994) 1.97
Complete structure of A/duck/Ukraine/63 influenza hemagglutinin gene: animal virus as progenitor of human H3 Hong Kong 1968 influenza hemagglutinin. Cell (1981) 1.96
Characterization of the 5'-terminal cap structures of early simian virus 40 mRNA. J Virol (1980) 1.95
Human TNF mutants with selective activity on the p55 receptor. Nature (1993) 1.91
Recombinant tumor necrosis factor: its effect and its synergism with interferon-gamma on a variety of normal and transformed human cell lines. Eur J Cancer Clin Oncol (1986) 1.89
Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro. Am J Pathol (1991) 1.88
Recombination signal sequence binding protein Jkappa is constitutively bound to the NF-kappaB site of the interleukin-6 promoter and acts as a negative regulatory factor. Mol Cell Biol (1997) 1.87
Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell. Proc Natl Acad Sci U S A (2000) 1.87
Cross-talk between nuclear receptors and nuclear factor kappaB. Oncogene (2006) 1.87
Membrane interleukin 1 induction on human endothelial cells and dermal fibroblasts. J Immunol (1987) 1.86
A method for the isolation of cytidylate series from ribonuclease T1-oligonucleotides. Anal Biochem (1975) 1.83
Localization of the 5' terminus of late SV40 mRNA. Nucleic Acids Res (1978) 1.80
Nucleotide sequence analysis of two simian virus 40 mutants with deletions in the region coding for the carboxyl terminus of the T antigen. J Virol (1979) 1.78
The antitumor function of tumor necrosis factor (TNF), I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity. J Exp Med (1988) 1.77
Human cytolytic T lymphocyte interactions with vascular endothelium and fibroblasts: role of effector and target cell molecules. J Immunol (1984) 1.75
Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome. J Exp Med (1986) 1.74
Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation. Proc Natl Acad Sci U S A (1997) 1.74
On codon usage. Nature (1979) 1.73
Expression of human fibroblast interferon gene in Escherichia coli. Nature (1980) 1.72